При оценка на резултатите не се установяват клинично значими промени в клирънса на ламотрижин.
Elderly Results of a population pharmacokinetic analysis including both young and elderly patients with epilepsy, enrolled in the same trials, indicated that the clearance of lamotrigine did not change to a clinically relevant extent.